HEPARIN INDUCED THROMBOCYTOPENIA

HEPARIN INDUCED THROMBOCYTOPENIA

BACKGROUND Unfractionated heparin and low-molecular-weight-heparins are commonly prescribed drugsin everyday clinical practice for treatment or prevention of thrombotic diseases. Heparinis used also for providing patency of various catheters. Heparin seldom causes heparininduced thrombocytopenia (HI...

Full description

Bibliographic Details
Main Authors:	Matija Kozak, Tadeja Dovč Drnovšek, Tanja Gmeiner Stopar
Format:	Article
Language:	English
Published:	Slovenian Medical Association 2008-03-01
Series:	Zdravniški Vestnik
Online Access:	http://vestnik.szd.si/index.php/ZdravVest/article/view/915

Similar Items

Serological and functional tests for the diagnosis of heparin-induced thrombocytopenia
by: Elvira Maličev, et al.
Published: (2012-02-01)

Heparin-induced thrombocytopenia
by: Prakash Shastri, et al.
Published: (2021-01-01)

Heparin-induced thrombocytopenia
by: Shaikh Nissar
Published: (2011-01-01)

Heparin-Induced Thrombocytopenia in Healthy Individuals with Continuous Heparin Infusion
by: Jonathan S. Williams, et al.
Published: (2018-01-01)

Autoimmune Heparin-Induced Thrombocytopenia
by: Theodore E. Warkentin
Published: (2023-11-01)

Heparin-induced thrombocytopenia: an update
by: Franchini Massimo
Published: (2005-10-01)

HEPARIN-INDUCED THROMBOCYTOPENIA (REVIEW)
by: S. A. Vasiliev, et al.
Published: (2019-06-01)

HEPARIN INDUCED THROMBOCYTOPENIA AND CARDIAC SURGERY
by: Maja Šoštarič, et al.
Published: (2008-03-01)

Assumption of heparin-induced thrombocytopenia in mucopolysaccharidoses
by: Liliya Aleksandrovna Osipova, et al.
Published: (2021-08-01)

Heparin-induced thrombocytopenia and COVID-19
by: Michelangelo Sartori, et al.
Published: (2021-03-01)

Heparin induced thrombocytopenia-type 2
by: Majeed Tanveer
Published: (2010-01-01)

Argatroban in the management of heparin-induced thrombocytopenia
by: Luciano Babuin, et al.
Published: (2010-09-01)

Prospective evaluation of heparin-induced thrombocytopenia expert probability and 4T scores in Chinese patients with suspected heparin-induced thrombocytopenia
by: Sen Li, et al.
Published: (2019-06-01)

Heparin-Induced Thrombocytopenia in Chronic Hemodialysis Patients
by: Rachelle Hamadi MD, et al.
Published: (2023-05-01)

THE THE HEPARIN INDUCED THROMBOCYTOPENIA IN CARDIAC SURGERY PATIENTS
by: Shakila Khadim, et al.
Published: (2020-12-01)

Re: Heparin-induced thrombocytopenia - Type 2
by: Yagnik Vipul
Published: (2011-01-01)

Safety and Efficacy of Argatroban in the Management of Heparin-Induced Thrombocytopenia
by: Bernd Saugel, et al.
Published: (2011-01-01)

Does ‘heparin-induced thrombocytopenia’ hit our minds?
by: Arun R. Thangavel, et al.
Published: (2016-08-01)

Intra‐cardiac thrombosis in the setting of heparin‐induced thrombocytopenia
by: Amr Mohamed
Published: (2021-08-01)

Safety and Efficacy of Argatroban in the Management of Heparin-Induced Thrombocytopenia
by: Bernd Saugel, et al.
Published: (2011-07-01)

Danaparoid thromboprophylaxis in pregnant women with heparin-induced thrombocytopenia
by: Woo, Y.L., et al.
Published: (2002)

HEPARIN-INDUCED THROMBOCYTOPENIA IN PATIENT POST LIVER TRANSPLANTATION
by: M. Sh. Hubutija, et al.
Published: (2018-04-01)

Commentary: Are platelet patterns repeated in delayed heparin-induced thrombocytopenia/heparin-induced thrombocytopenia and thrombosis syndrome after cardiac surgery?Central Message
by: Robert S. Kramer, MD, et al.
Published: (2020-12-01)

DETERMINATION OF FETAL BLOOD GROUP IN PREGNANCY
by: Irena Bricl, et al.
Published: (2004-12-01)

Heparin‐induced thrombocytopenia in end‐stage renal disease: Reliability of the PF4‐heparin ELISA
by: Julie Kelly, et al.
Published: (2021-07-01)

Incidence of anti-heparin/platelet factor 4 antibodies and heparin-induced thrombocytopenia in medical patients
by: Mahmut Yüksel, et al.
Published: (2009-12-01)

Detection of Platelet-Activating Antibodies Associated with Heparin-Induced Thrombocytopenia
by: Brigitte Tardy, et al.
Published: (2020-04-01)

Heparin-induced thrombocytopenia: a rare presentation with skin necrosis
by: Filipa David, et al.
Published: (2023-10-01)

Repeated in situ arterial thrombolysis in severe heparin-induced thrombocytopenia
by: Roxane Varone, et al.
Published: (2023-06-01)

The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19
by: Jori E. May, et al.
Published: (2020-08-01)

Management of the heparin induced thrombocytopenia in the course of acute myocardial infarction
by: Ali Çoner, et al.
Published: (2020-07-01)

How to improve the management of a patient with heparin-induced thrombocytopenia?
by: Anetta Undas
Published: (2019-11-01)

Delayed‐onset heparin‐induced thrombocytopenia complicated with saddle embolus
by: Faezeh Sadat Naji, et al.
Published: (2022-07-01)

Heparin: Induced thrombocytopenia: Incidence and laboratory approach to diagnosis in Indians
by: Jyoti Kotwal, et al.
Published: (2014-01-01)

Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia
by: Payel Datta, et al.
Published: (2021-09-01)

How to Solve the Conundrum of Heparin-Induced Thrombocytopenia during Cardiopulmonary Bypass
by: Etienne Revelly, et al.
Published: (2023-01-01)

Heparin-Induced Thrombocytopenia in Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation
by: Enzo Lüsebrink, et al.
Published: (2023-01-01)

COVID-19 Vaccination-Associated Spontaneous Heparin-Induced Thrombocytopenia Syndrome
by: Prakash Vishnu, et al.
Published: (2023-10-01)

Falsely positive heparin‐induced thrombocytopenia antibody testing in severe hyperbilirubinemia
by: Daniel Egert, et al.
Published: (2021-10-01)

A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia
by: Nikola Ivetic, et al.
Published: (2019-11-01)